SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-007726
Filing Date
2023-03-15
Accepted
2023-03-15 16:02:02
Documents
91
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1826563
2 ex4-6.htm EX-4.6 40206
3 ex10-17.htm EX-10.17 25349
4 ex10-18.htm EX-10.18 32541
5 ex10-19.htm EX-10.19 35342
6 ex10-20.htm EX-10.20 31956
7 ex21-1.htm EX-21.1 4966
8 ex23-1.htm EX-23.1 3911
9 ex31-1.htm EX-31.1 11448
10 ex31-2.htm EX-31.2 11902
11 ex32-1.htm EX-32.1 10806
12 form10-k_001.jpg GRAPHIC 147648
13 form10-k_002.jpg GRAPHIC 56195
14 form10-k_003.jpg GRAPHIC 95786
15 form10-k_004.jpg GRAPHIC 87277
16 form10-k_005.jpg GRAPHIC 99672
  Complete submission text file 0001493152-23-007726.txt   8560038

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE mtnb-20221231.xsd EX-101.SCH 49622
18 XBRL CALCULATION FILE mtnb-20221231_cal.xml EX-101.CAL 64338
19 XBRL DEFINITION FILE mtnb-20221231_def.xml EX-101.DEF 172396
20 XBRL LABEL FILE mtnb-20221231_lab.xml EX-101.LAB 432556
21 XBRL PRESENTATION FILE mtnb-20221231_pre.xml EX-101.PRE 327948
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 915386
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38022 | Film No.: 23735072
SIC: 2834 Pharmaceutical Preparations